G8126 – Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase

Long description

Patient with a diagnosis of major depression documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase

Short description

Pt treat w/antidepress12wks

Pricing indicator

00 Not separately priced by Part B (bundled, not covered or Part A only)

Medicare coverage

C Carrier judgment – coverage decided by the Medicare contractor

BETOS category

M5D Specialist - other

Added

January 1, 2006

Last change

January 1, 2015 – No change

Termination date

December 31, 2014

Nearby G codes

• G6051 – Flurazepam
• G6052 – Meprobamate
• G6053 – Methadone
• G6054 – Methsuximide
• G6055 – Nicotine
• G6056 – Opiate(s), drug and metabolites, each procedure
• G6057 – Phenothiazine
• G6058 – Drug confirmation, each procedure
• G8127 – Patient with a diagnosis of major depression not documented as being treated with antidepressant medication during the entire 84 day (12 week) acute treatment phase
• G8128 – Clinician documented that patient was not an eligible candidate for antidepressant medication during the entire 12 week acute treatment phase measure
• G8395 – Left ventricular ejection fraction (lvef) >= 40% or documentation as normal or mildly depressed left ventricular systolic function
• G8396 – Left ventricular ejection fraction (lvef) not performed or documented
• G8397 – Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy
• G8398 – Dilated macular or fundus exam not performed
• G8399 – Patient with documented results of a central dual-energy x-ray absorptiometry (dxa) ever being performed
• G8400 – Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given